Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17030101 | 0.94 | MEN1 (0.46) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR | |
| SCHEMBL17029960 | 0.86 | — | — | |
| SCHEMBL17030100 | 0.85 | TDP1 (0.42) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR | |
| SCHEMBL17472392 | 0.81 | CYP1A2 (0.41) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR | |
| SCHEMBL10728146 | 0.80 | SMN1; SMN2 (0.53) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR | |
| SCHEMBL10311296 | 0.79 | TSHR (0.53) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR | |
| SCHEMBL17030102 | 0.77 | TSHR (0.43) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR | |
| SCHEMBL17030222 | 0.76 | GMNN (0.44) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR | |
| SCHEMBL7058449 | 0.76 | — | — | |
| SCHEMBL3455317 | 0.75 | MEN1 (0.56) | MEN1CYP1A2KMT2ASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150250217-A1 | SALTY TASTE-ENHANCING AGENT AND MANUFACTURING METHOD THEREFOR, AND SALTY TASTE-ENHANCING METHOD | NISSAN FOODS HOLDINGS CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
| EP-2910130-A1 | SALTY TASTE-ENHANCING AGENT AND MANUFACTURING METHOD THEREFOR, AND SALTY TASTE-ENHANCING METHOD | Nissin Foods Holdings Co., Ltd. (JP) | 2015-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150250217-A1 | SALTY TASTE-ENHANCING AGENT AND MANUFACTURING METHOD THEREFOR, AND SALTY TASTE-ENHANCING METHOD | TAS2R8, TAS2R13, TAS2R38 | MEN1 957/4885CYP1A2 4676/4885KMT2A 2646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.